We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novo Nordisk Agrees to $100 Million Settlement, But Admits No Guilt
Novo Nordisk Agrees to $100 Million Settlement, But Admits No Guilt
Novo Nordisk has agreed to a $100 million settlement in a 2017 class action lawsuit that accused the company of making kickbacks to pharmacy benefit managers (PBMs) and failing to disclose information about its revenues related to insulin.